Matthew I. Milowsky, MD

The George Gabriel and Frances Gable Villere Distinguished Professor of Bladder and Genitourinary Cancer Research
Section Chief, Genitourinary Oncology
Co-Director, Urologic Oncology Program
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Lecture Description

Genitourinary malignances will account for approximately 20% of newly diagnosed cancers in 2021. Recent research advances in prostate, bladder, and kidney cancers utilizing new biomarkers and imaging tools, radiolabeled therapy, targeted therapy, immunotherapy and antibody-drug conjugates have led to new management approaches associated with significant improvements in patient outcomes.

Learning Objectives:

• Describe new PSMA-directed approaches in the imaging and management of patients with prostate cancer.
• Review recent advances in systemic therapy for patients with muscle-invasive and metastatic bladder cancer.
• Discuss the use of immunotherapy and targeted therapy approaches in the management of advanced kidney cancer.